Institutional Repository of Key Laboratory of Mental Health, CAS
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders | |
Kong, Qingyan1,2; Han, Buxin1,2,3 | |
第一作者 | Qingyan Kong |
通讯作者邮箱 | [email protected] (buxin han) |
心理所单位排序 | 1 |
摘要 | IntroductionAnxiety disorders are characterized by widespread and persistent anxiety or recurrent panic attacks. As a result of their high prevalence, chronicity, and comorbidity, patients' quality of life and functioning are severely compromised. However, several patients do not receive treatment.Areas coveredThis review discusses the effectiveness, safety, and limitations of major medications and cognitive bias modification (CBM) for treating anxiety disorders. The possibility of combined treatment is also discussed in the literature. Furthermore, drawing on Chinese cultural perspectives, the authors suggest that anxiety can be recognized, measured, and coped with at three levels of skill (), vision (), and Tao ().Expert opinionThe combination of pharmacotherapy and CBM is possibly more effective in treating anxiety disorders than either treatment alone. However, clinicians and patients should participate in the joint decision-making process and consider comprehensive factors. Moderate anxiety has adaptive significance. In the coming years, by combining the downward analytical system of western culture with the upward integrative system of Chinese culture, a comprehensive understanding of anxiety and anxiety disorders should be established, rather than focusing only on their treatment. |
关键词 | Anxiety disorders cognitive bias modification Chinese culture pharmacotherapy treatment |
2024-05-03 | |
语种 | 英语 |
DOI | 10.1080/14737175.2024.2334847 |
发表期刊 | EXPERT REVIEW OF NEUROTHERAPEUTICS |
ISSN | 1473-7175 |
卷号 | 24期号:5页码:517-525 |
期刊论文类型 | 综述 |
收录类别 | SCI |
资助项目 | Social Science Foundation of China[20VYJ041] |
出版者 | TAYLOR & FRANCIS LTD |
WOS关键词 | SOCIAL ANXIETY ; PREGABALIN ; EFFICACY ; ATTENTION ; CARE ; COMORBIDITY ; FEAR ; PHARMACOLOGY ; PREVALENCE ; RECURRENCE |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy |
WOS类目 | Clinical Neurology ; Pharmacology & Pharmacy |
WOS记录号 | WOS:001195013400001 |
WOS分区 | Q2 |
资助机构 | Social Science Foundation of China |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.psych.ac.cn/handle/311026/47547 |
专题 | 中国科学院心理健康重点实验室 |
通讯作者 | Han, Buxin |
作者单位 | 1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China 2.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China 3.Chinese Acad Sci, Inst Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China |
第一作者单位 | 中国科学院心理健康重点实验室 |
通讯作者单位 | 中国科学院心理健康重点实验室; 中国科学院心理研究所 |
推荐引用方式 GB/T 7714 | Kong, Qingyan,Han, Buxin. Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS,2024,24(5):517-525. |
APA | Kong, Qingyan,&Han, Buxin.(2024).Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders.EXPERT REVIEW OF NEUROTHERAPEUTICS,24(5),517-525. |
MLA | Kong, Qingyan,et al."Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders".EXPERT REVIEW OF NEUROTHERAPEUTICS 24.5(2024):517-525. |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
Pharmacotherapy and (759KB) | 期刊论文 | 出版稿 | 限制开放 | CC BY-NC-SA | 请求全文 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Kong, Qingyan]的文章 |
[Han, Buxin]的文章 |
百度学术 |
百度学术中相似的文章 |
[Kong, Qingyan]的文章 |
[Han, Buxin]的文章 |
必应学术 |
必应学术中相似的文章 |
[Kong, Qingyan]的文章 |
[Han, Buxin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论